Nr. 1, 2008 - Romanian Journal of Cardiology

Revista Română de Cardiologie
Vol. XXIII, Nr. 1, 2008
Ghid de diagnostic şi tratament al sindroamelor coronariene acute
fără supradenivelare de segment ST
HINT
HOPE
ICTUS
IMPACT-2
INTERACT
IONA
ISAR
ISAR-COOL
Off)
ISAR-REACT-2
MATE
MINAP
OASIS
OASIS-5
OASIS-6
PRISM
PRISM-PLUS
PROVE-IT
PURSUIT
RESTORE
(Holland Interuniversity Nifedipine/metopropol Trial)
(Heart Outcomes Prevention Evaluation study)
(Invasive versus Conservative Treatment in Unstable Coronary
Syndrome)
(Integrilin to Minimize Platelet Aggregation and Coronary
Thrombosis II)
(Integrilin and Enoxoparin Randomized Assessment on
Acute Coronary Syndrome Treatment)
(Impact of Nicorandil in Angina)
(Intracoronary Stenting and Antithrombotic Regimen)
(Intracoronary Stenting With Antithrombotic Regimen Cooling-
(Intracoronary Stenting and Antithrombo tic Regimen: Rapid
Early Action for Coronary Treatment 2)
(Medicine vs. Angiography in Thrombolytic Exclusion)
(National Audit of Myocardial Infarction Project)
(Organization to Assess Strategies for Ischaemic Syndromes
pilot study)
(Organization to Assess Strategies in Acute Ischemic Syndromes
5)
(Organization for the Assessment of Strategies for Ischemic
Syndromes 6)
(Platelet Receptor Inhibition in Ischaemic Syn drome
Management)
(Platelet Receptor Inhibition in Ischaemic Syndrome
Management in Patients Limited by Unstable Signs and
Symptoms)
(Pravastatin or Atorvastatin Evaluation and Infection Therapy
trial)
(Platelet Glycoprotein IIb/IIIa in Unstable Angina; Receptor
Suppression Using Integrilin Therapy)
(Randomized Efficacy Study of Tirofiban for Outcomes and
Restenosis)
RITA-3 (Randomized Intervention Trial of unstable Angina 3)
STEEPLE (The Safety and Efficacy of Enoxaparin In PCI Patients In
International Randomized Evaluation)
SYNERGY (Superior Yield of the New strategy of Enoxa parin,
Revascularization and Glycoprotein IIb/IIIa inhibitors)
TACTICS-TIMI-18 (Treat Angina with Aggrastat and Determine Cost of
Therapy with an Invasive or Conserva tive Strategy)
TARGET
(Tirofiban and Reopro Give Similar Efficacy Outcomes)
TENACITY (Tirofiban Novel Dosing vs. Abciximab with Evaluation of
Clopidogrel and Inhibition of Thrombin Study)
TIMI
(Thrombolysis in Myocardial Infarction)
TIMI-11A (Thrombolysis in Myocardial Infarction Phase 11A)
TIMI-11B (Thrombolysis in Myocardial Infarction Phase 11B)
TIMI-3B
(Thrombolysis in Myocardial Ischaemia Phase III)
VANQWISH (Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital)
MULŢUMIRI
Noi suntem recunoscători Fionei Ecarnot pentru suportul
important şi asistenţa editorială pe tot parcursul
elaborării acestui document.
BIBLIOGRAFIE
1. Murray CJ, Lopez AD. Alternative projections of mortality and disability
by cause 1990-2020: Global Burden of Disease Study. Lancet
1997;349:1498-1504.
2. Van de Werf F, Ardissino D, Betriu A, Cokkinos DV, Falk E, Fox KA,
Julian D, Lengyel M, Neumann FJ, Ruzyllo W, Thygesen C, Underwood
SR, Vahanian A, Verheugt FW, Wijns W. Management of acute
myocardial infarction in patients presenting with ST-segment elevation.
The Task Force on the Management of Acute Myocardial Infarction
of the European Society of Cardiology. Eur Heart J 2003;24:28-
66.
3. Bertrand ME, Simoons ML, Fox KA, Wallentin LC, Hamm CW,
McFadden E,De Feyter PJ, Specchia G, Ruzyllo W. Management of
acute coronary syndromes in patients presenting without persistent
ST-segment elevation. Eur Heart J 2002;23:1809-1840.
4. Cook RJ, Sackett DL. The number needed to treat: a clinically useful
measure of treatment effect. BMJ 1995;310:452-454.
5. Alpert JS, Thygesen K, Antman EM, Bassand JP. Myocardial infarction
redefined—a consensus document of The Joint European Society
of Cardiology/American College of Cardiology Committee for the
redefini tion of myocardial infarction. Eur Heart J 2000;21:1502-1513.
6. GRACE Investigators. Rationale and design of the GRACE (Global
Registry of Acute Coronary Events) project: a multinational registry
of patients hospitalized with acute coronary syndromes. Am Heart J
2001;141:190-199.
7. Birkhead JS, Walker L, Pearson M, Weston C, Cunningham AD,
Rickards AF. Improving care for patients with acute coronary syndromes:
initial results from the National Audit of Myocardial Infarction
Project (MINAP). Heart 2004;90:1004-1009.
8. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf
F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Ave zum
A,Flather MD, Fox KA. A validated prediction model for all for ms
of acute coronary syndrome: estimating the risk of 6-month postdischarge
death in an international registry. JAMA 2004;291:2727-2733.
9. Fox KA, Goodman SG, Klein W, Brieger D, Steg PG, Dabbous O, Avezum
A. Management of acute coronary syndromes. Variations in prac
tice and outcome; findings from the Global Registry of Acute Coro n-
ary Events (GRACE). Eur Heart J 2002;23:1177-1189.
10. Hasdai D, Behar S, Boyko V, Danchin N, Bassand JP, Battler A. Cardiac
biomarkers and acute coronary syndromes—the Euro Heart Survey
of Acute Coronary Syndromes Experience. Eur Heart J 2003; 24:
1189-1194.
11. Hasdai D, Behar S, Wallentin L, Danchin N, Gitt AK, Boersma E,
Fioretti PM, Simoons ML, Battler A. A prospective survey of the charac
teristics, treatments and outcomes of patients with acute coro nary
syn dromes in Europe and the Mediterranean basin; the Euro Heart
Survey of Acute Coronary Syndromes (Euro Heart Survey ACS). Eur
Heart J 2002;23:1190-1201.
12. Hoekstra JW, Pollack CV Jr, Roe MT, Peterson ED, Brindis R,
Harrington RA, Christenson RH, Smith SC, Ohman EM, Gibler WB.
Impro ving the care of patients with non-ST-elevation acute coronary
syndromes in the emergency department: the CRUSADE initiative.
Acad Emerg Med 2002;9:1146-1155.
13. Lev EI, Battler A, Behar S, Porter A, Haim M, Boyko V, Hasdai D.
Fre que ncy, characteristics, and outcome of patients hospitalized with
acute coronary syndromes with undetermined electrocardiographic
pat ter ns. Am J Cardiol 2003;91:224-227.
14. Stenestrand U, Wallentin L. Early statin treatment following acute
myo cardial infarction and 1-year survival. JAMA 2001;285:430-436.
15. Stenestrand U, Wallentin L. Early revascularisation and 1-year survival
in 14-day survivors of acute myocardial infarction: a prospective cohort
study. Lancet 2002;359:1805-1811.
16. Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Recent changes in attack
and survival rates of acute myocardial infarction (1975 through 1981).
The Worcester Heart Attack Study. JAMA 1986;255:2774-2779.
17. Bata IR, Gregor RD, Eastwood BJ, Wolf HK. Trends in the incidence
of acute myocardial infarction between 1984 and 1993—The Halifax
County MONICA Project. Can J Cardiol 2000; 16:589-595.
18. Fox KA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The
ENACTstudy: a pan-European survey of acute coronary syndromes.
European Network for Acute Coronary Treatment. Eur Heart J 2000;
21:1440-1449.
19. Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D,
Gore JM.Twenty-two year (1975 to 1997) trends in the incidence,
in-hospital and long-term case fatality rates from initial Q-wave and
non-Q-wave myo cardial infarction: a multi-hospital, communitywide
perspective. J Am Coll Cardiol 2001;37:1571-1580.
20. van der Pal-de Bruin KM, Verkleij H, Jansen J, Bartelds A, Kromhout
D. The incidence of suspected myocardial infarction in Dutch general
prac tice in the period 1978-1994. Eur Heart J 1998;19:429-434.